Detalles de la búsqueda
1.
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
BMC Med
; 20(1): 398, 2022 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372873
2.
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.
Mol Cancer
; 18(1): 181, 2019 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823788
3.
Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Cancer
; 125(20): 3535-3544, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31287555
4.
Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.
Mol Cancer
; 22(1): 132, 2023 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37573296
5.
Correction: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
BMC Med
; 21(1): 15, 2023 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36617568
6.
The mechanism of lncRNAs in the crosstalk between epithelial-mesenchymal transition and tumor microenvironment for early colon adenocarcinoma based on molecular subtyping.
Front Genet
; 13: 997739, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36467998
7.
Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients.
J Cancer Res Clin Oncol
; 147(3): 725-737, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387041
8.
Management of Non-Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study.
Clin Lung Cancer
; 22(1): e25-e34, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32839132
9.
Reversal of ABCB1-related multidrug resistance by ERK5-IN-1.
J Exp Clin Cancer Res
; 39(1): 50, 2020 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164732
10.
Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo.
Exp Mol Med
; 52(6): 989-990, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32555512
11.
Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice.
Front Oncol
; 10: 581729, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33163410
12.
Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo.
Exp Mol Med
; 49(3): e303, 2017 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28303028
13.
Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
Clin Lung Cancer
; 18(3): e179-e186, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28185793
14.
Long-lasting response to third-line crizotinib treatment in a patient with non-small cell lung cancer with brain metastases and poor performance status.
Thorac Cancer
; 7(5): 619-622, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27766783
15.
Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.
Onco Targets Ther
; 9: 5729-5736, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27703372
Resultados
1 -
15
de 15
1
Próxima >
>>